A-Alpha Bio is a biotechnology company accelerating drug discovery by measuring protein-protein interactions at an unprecedented scale. Their proprietary AlphaSeq platform combines synthetic biology and next-generation sequencing to quantitatively assess millions of these interactions simultaneously. This technology enables the identification and optimization of antibodies, small molecules, and other biologics, aiming to bring more effective and safer therapeutics to patients faster. A-Alpha Bio collaborates with pharmaceutical and biotech partners to tackle challenging therapeutic targets across various disease areas.
The Seattle headquarters serves as the central hub for A-Alpha Bio's research and development, laboratory operations, business development, and corporate administration.
Located in Seattle's vibrant biotech ecosystem, the facility likely houses state-of-the-art laboratories equipped for molecular biology, yeast display, next-generation sequencing, and computational analysis.
A-Alpha Bio fosters a collaborative, innovative, and science-driven work environment. Employees are typically passionate about leveraging cutting-edge technology to solve complex biological problems and impact human health.
The headquarters is crucial for A-Alpha Bio's core mission, as it's where their proprietary AlphaSeq platform is developed, refined, and applied to drug discovery projects.
While A-Alpha Bio's primary operations are based in its Seattle headquarters, its impact and collaborations are global. The company partners with pharmaceutical and biotechnology companies worldwide, applying its AlphaSeq platform to diverse drug discovery programs. Its research and technology contribute to the global scientific community's efforts in developing new therapeutics.
999 N Northlake Way, Suite 150
Seattle
WA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, A-Alpha Bio' leadership includes:
A-Alpha Bio has been backed by several prominent investors over the years, including:
A-Alpha Bio has seen strategic additions to its leadership team in the past year to bolster its drug discovery and business development capabilities. No major executive exits have been publicly noted.
Discover the tools A-Alpha Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
A-Alpha Bio likely uses common professional email formats for its employees. The most probable convention is a combination of the employee's first name or initial and last name.
[first_initial][last]@aalphabio.com
Format
dyounger@aalphabio.com
Example
80%
Success rate
Business Wire • October 26, 2023
A-Alpha Bio entered into a research collaboration and license agreement with Kyowa Kirin to discover and characterize high-affinity antibodies against multiple therapeutic targets. A-Alpha Bio will receive an upfront payment and is eligible for research, development, and commercial milestones, plus royalties....more
Business Wire • May 16, 2023
A-Alpha Bio announced the appointment of Bob L Harris as Chief Business Officer. Harris brings over 20 years of experience in biopharmaceutical business development, strategy, and commercialization to the company....more
PR Newswire • January 9, 2023
A-Alpha Bio announced an expansion of its collaboration with Amgen to discover and characterize molecular glue targets. The expanded collaboration will leverage A-Alpha Bio's AlphaSeq platform to identify novel protein-protein interactions that can be stabilized by molecular glues....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including A-Alpha Bio, are just a search away.